BayMark Health Services Completes Strategic Transaction to Strengthen Financial Foundation and Support Continued Growth
BayMark Health Services Completes Strategic Transaction to Strengthen Financial Foundation and Support Continued Growth
BayMark Health Services (“BayMark” or the “Company”), a trusted leader in substance use disorder treatment and recovery services throughout North America, today announced it has successfully finalized a strategic transaction with its existing lenders (the “Transaction”). The Transaction has unanimous support across its capital structure, materially strengthens the Company’s balance sheet, and provides the Company with growth capital. This strengthened financial foundation complements the Company’s robust operating performance and provides a clear path forward for long-term stability and sustainable growth. As a result of the Transaction, BayMark is now significantly better positioned to continue providing its best-in-class substance use disorder treatment to over 70,000 patients every day.
"This agreement reflects the strength of BayMark's business and the confidence our financial partners have in our long-term vision," said Marshal Salomon, Chief Executive Officer of BayMark. "With a stronger financial position, BayMark will continue to serve as the provider of choice in communities across North America, delivering a full continuum of outpatient and inpatient addiction treatment services. This transaction positions BayMark for continued investment in our teams, treatment facilities, and care delivery capabilities to meet the evolving needs of individuals seeking treatment."
BayMark continues to operate without interruption. All treatment sites, outpatient and inpatient programs, and clinical services remain fully operational. Patients, teammates, clinicians, and partners should not expect any change in the quality or availability of care. All existing contracts, service agreements, and partnerships remain in full force and effect.
About BayMark Health Services
BayMark Health Services is North America’s leading provider of comprehensive substance use disorder treatment and recovery services. Through evidence-based practices and a patient-centered approach, BayMark empowers individuals to overcome the challenges of addiction and achieve lasting recovery. To learn more, visit BayMark.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261019018604/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Buy Trading at Big Discounts
This Once-Hot AI Stock Now Looks Deeply Undervalued
What 7 Key Market Indicators Are Telling Investors Right Now
Don’t Overlook the Income Side of Fixed Income
United States